The COVID-19 Updates and Situation Report brings together news about the Global Fund partnership’s response to the pandemic. We publish a new issue when there are developments. The situation reports and news are brought together here.
Due to the changing nature of the COVID-19 pandemic and contributing factors, the Global Fund will be supporting implementing countries to urgently reinvest COVID-19 Response Mechanism (C19RM) funds, where the initial intent of these investments no l...
The COVID-19 pandemic is evolving and so should C19RM investments. The Global Fund would like to support implementing countries to rethink how these funds need to be adapted to countries’ needs in a very dynamic pandemic context.
In this operational update, we would like to give you an update on COVID-19 testing and therapeutics that can be currently supported through the Global Fund’s COVID-19 Response Mechanism (C19RM), following WHO guidelines.
The C19RM Health Products Management Template has been updated to include TB cartridges (GeneXpert and Truenat). Principal Recipients can now procure these health products to support integrated testing of tuberculosis and COVID-19 under C19RM 2021 fi...
The Global Fund is seeking information on the readiness and use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing in countries implementing Global Fund-supported programs.